Literature DB >> 26989915

Pediatric Brain Tumors: Current Knowledge and Therapeutic Opportunities.

John Glod1, Gilbert J Rahme, Harpreet Kaur, Eric H Raabe, Eugene I Hwang, Mark A Israel.   

Abstract

Great progress has been made in many areas of pediatric oncology. However, tumors of the central nervous system (CNS) remain a significant challenge. A recent explosion of data has led to an opportunity to understand better the molecular basis of these diseases and is already providing a foundation for the pursuit of rationally chosen therapeutics targeting relevant molecular pathways. The molecular biology of pediatric brain tumors is shifting from a singular focus on basic scientific discovery to a platform upon which insights are being translated into therapies.

Entities:  

Mesh:

Year:  2016        PMID: 26989915      PMCID: PMC5003110          DOI: 10.1097/MPH.0000000000000551

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  161 in total

1.  Post-operative radiation improves survival in children younger than 3 years with intracranial ependymoma.

Authors:  Matthew Koshy; Shayna Rich; Thomas E Merchant; Usama Mahmood; William F Regine; Young Kwok
Journal:  J Neurooncol       Date:  2011-06-03       Impact factor: 4.130

Review 2.  Recent developments and current concepts in medulloblastoma.

Authors:  N U Gerber; M Mynarek; K von Hoff; C Friedrich; A Resch; S Rutkowski
Journal:  Cancer Treat Rev       Date:  2013-12-06       Impact factor: 12.111

3.  WEE1 kinase inhibition enhances the radiation response of diffuse intrinsic pontine gliomas.

Authors:  Viola Caretti; Lotte Hiddingh; Tonny Lagerweij; Pepijn Schellen; Phil W Koken; Esther Hulleman; Dannis G van Vuurden; W Peter Vandertop; Gertjan J L Kaspers; David P Noske; Thomas Wurdinger
Journal:  Mol Cancer Ther       Date:  2012-12-27       Impact factor: 6.261

4.  Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

Authors:  Hendrik Witt; Stephen C Mack; Marina Ryzhova; Sebastian Bender; Martin Sill; Ruth Isserlin; Axel Benner; Thomas Hielscher; Till Milde; Marc Remke; David T W Jones; Paul A Northcott; Livia Garzia; Kelsey C Bertrand; Andrea Wittmann; Yuan Yao; Stephen S Roberts; Luca Massimi; Tim Van Meter; William A Weiss; Nalin Gupta; Wiesia Grajkowska; Boleslaw Lach; Yoon-Jae Cho; Andreas von Deimling; Andreas E Kulozik; Olaf Witt; Gary D Bader; Cynthia E Hawkins; Uri Tabori; Abhijit Guha; James T Rutka; Peter Lichter; Andrey Korshunov; Michael D Taylor; Stefan M Pfister
Journal:  Cancer Cell       Date:  2011-08-16       Impact factor: 31.743

5.  Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.

Authors:  Ian F Pollack; Ronald L Hamilton; C David James; Sydney D Finkelstein; Judith Burnham; Allan J Yates; Emiko J Holmes; Tianni Zhou; Jonathan L Finlay
Journal:  J Neurosurg       Date:  2006-11       Impact factor: 5.115

6.  Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

Authors:  R J Packer; J Ater; J Allen; P Phillips; R Geyer; H S Nicholson; R Jakacki; E Kurczynski; M Needle; J Finlay; G Reaman; J M Boyett
Journal:  J Neurosurg       Date:  1997-05       Impact factor: 5.115

7.  The potential of theragnostic ¹²⁴I-8H9 convection-enhanced delivery in diffuse intrinsic pontine glioma.

Authors:  Neal Luther; Zhiping Zhou; Pat Zanzonico; Nai-Kong Cheung; John Humm; Mark A Edgar; Mark M Souweidane
Journal:  Neuro Oncol       Date:  2014-02-12       Impact factor: 12.300

8.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

Review 9.  Management of pediatric and adult patients with medulloblastoma.

Authors:  Allison M Martin; Eric Raabe; Charles Eberhart; Kenneth J Cohen
Journal:  Curr Treat Options Oncol       Date:  2014-12

Review 10.  MAPK pathway activation in pilocytic astrocytoma.

Authors:  David T W Jones; Jan Gronych; Peter Lichter; Olaf Witt; Stefan M Pfister
Journal:  Cell Mol Life Sci       Date:  2011-12-13       Impact factor: 9.261

View more
  7 in total

1.  Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors.

Authors:  Nathan J Robison; Kee Kiat Yeo; Adrian P Berliner; Jemily Malvar; Michael A Sheard; Ashley S Margol; Robert C Seeger; Teresa Rushing; Jonathan L Finlay; Richard Sposto; Girish Dhall
Journal:  J Neurooncol       Date:  2018-02-09       Impact factor: 4.130

Review 2.  Molecular Basis of Pediatric Brain Tumors.

Authors:  Alexia Klonou; Christina Piperi; Antonios N Gargalionis; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2017-07-26       Impact factor: 3.843

Review 3.  Novel Pharmacological Treatment Options in Pediatric Glioblastoma-A Systematic Review.

Authors:  Johanna Wyss; Nicole Alexandra Frank; Jehuda Soleman; Katrin Scheinemann
Journal:  Cancers (Basel)       Date:  2022-06-06       Impact factor: 6.575

Review 4.  Advances in the classification of pediatric brain tumors through DNA methylation profiling: From research tool to frontline diagnostic.

Authors:  Rahul Kumar; Anthony P Y Liu; Brent A Orr; Paul A Northcott; Giles W Robinson
Journal:  Cancer       Date:  2018-09-26       Impact factor: 6.860

Review 5.  EZH2, HIF-1, and Their Inhibitors: An Overview on Pediatric Cancers.

Authors:  Marco Papale; Elisabetta Ferretti; Giuseppe Battaglia; Diana Bellavia; Antonello Mai; Marco Tafani
Journal:  Front Pediatr       Date:  2018-11-19       Impact factor: 3.418

6.  A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement.

Authors:  Yiqun Zhang; Fengju Chen; Lawrence A Donehower; Michael E Scheurer; Chad J Creighton
Journal:  Nat Commun       Date:  2021-02-10       Impact factor: 14.919

7.  DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker.

Authors:  Nasim Azizgolshani; Curtis L Petersen; Youdinghuan Chen; Joshua J Levy; Lucas A Salas; Laurent Perreard; Lananh N Nguyen; Brock C Christensen
Journal:  Clin Epigenetics       Date:  2021-09-19       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.